2019
Modulatory Role of SIRT1 and Resistin as Therapeutic Targets in Patients with Aortic Valve Stenosis
Samiei N, Hosseini S, Maleki M, Moradi L, Joghataei M, Arabian M. Modulatory Role of SIRT1 and Resistin as Therapeutic Targets in Patients with Aortic Valve Stenosis. Archives Of Medical Research 2019, 50: 333-341. PMID: 31677538, DOI: 10.1016/j.arcmed.2019.10.001.Peer-Reviewed Original ResearchConceptsSilent information regulator 1Aortic valve stenosisPeripheral blood mononuclear cellsResistin levelsValve stenosisAS groupExpression of SIRT1Modulatory roleAortic valve replacementLevels of resistinBlood mononuclear cellsInformation regulator 1Effects of resveratrolAS preventionValve replacementPharmacological therapyMononuclear cellsResistin expressionSIRT1 expressionTargeted therapySIRT1 levelsTherapeutic effectHealthy subjectsNovel biomarkersTherapeutic target
2016
Sirtuin 1 activation alleviates cholestatic liver injury in a cholic acid–fed mouse model of cholestasis
Kulkarni SR, Soroka CJ, Hagey LR, Boyer JL. Sirtuin 1 activation alleviates cholestatic liver injury in a cholic acid–fed mouse model of cholestasis. Hepatology 2016, 64: 2151-2164. PMID: 27639250, PMCID: PMC5115990, DOI: 10.1002/hep.28826.Peer-Reviewed Original ResearchConceptsCholestatic liver injuryLiver injurySRT1720 administrationSIRT1 expressionCa dietMouse modelFibroblast growth factor 15Proliferator-activated receptor gamma coactivator 1Multidrug resistance-associated protein 2Peroxisome proliferator-activated receptor gamma coactivator 1Hepatic BA compositionHepatic BA synthesisGrowth factor 15Receptor gamma coactivator 1Resistance-associated protein 2Plasma alanine aminotransferasePlasma BA concentrationsCultured primary human hepatocytesNovel therapeutic targetSirtuin 1 activationFarnesoid X receptorMiR-34a expressionSIRT1 messenger RNACytochrome P450 7A1Bile acid sensor
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply